3 citations
,
July 2022 in “European Journal of Dermatology” In this study, researchers using multistate modeling reported that patients with psoriasis treated with brodalumab had a higher probability of achieving and maintaining a therapeutic response compared to those treated with ustekinumab over 52 weeks, based on absolute PASI measurements.
June 2026 in “International Journal of Ayurveda and Pharma Research” This study documented a case where Ayurvedic treatments for plaque psoriasis significantly reduced the severity of symptoms, as measured by an 84% improvement in the Psoriasis Area and Severity Index score from 6.5 to 1.04.
January 2026 in “Clinics and Practice” In this retrospective case series, baricitinib showed effectiveness in treating alopecia areata, with some potential benefits for psoriasis, but it may not be suitable for managing psoriatic arthritis in patients with these coexisting conditions.
July 2025 in “Kottakkal Journal of Ayurvedic Medicine And Research” In this case study, a 61-year-old male with chronic plaque psoriasis showed marked improvement in symptoms and quality of life after undergoing sodhana therapy and Bakuchi rasayana treatment, with a reduction in PASI score from 14.5 to 4.8 reported by the researchers.
June 2025 in “Preprints.org” In this retrospective case series, baricitinib showed effectiveness in treating severe alopecia areata but had mixed results for psoriasis and was not optimal for psoriatic arthritis in patients with coexisting conditions, suggesting further studies are needed.